Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$22.20 USD
-0.67 (-2.93%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $22.20 0.00 (0.00%) 5:34 PM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Brokerage Reports
Edgewise Therapeutics, Inc. [EWTX]
Reports for Purchase
Showing records 21 - 40 ( 73 total )
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Kickstart or False Start? What January Tells Us about Biotech Annual Returns
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Moving To A New Beat: Looking Closer At EDG-7500 In HCM
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Could 2024 Finally Be Biotech''s Breakthrough Year?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EWTX 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Will EWTX OutFOX The Competition With EDG-5506? Can''t Wait To Find Out
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Notes From The (Virtual) Road... DMD, Cardiac GLP-1s In Focus With EWTX
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Living in the Fast (Fiber) Lane -- Check In With EWTX Management
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Don''t Let The LYNX Creep Up On You -- Phase 2 EDG-5506 Data On Track For 4Q23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Life In The Fast Lane - ARCH Data Continues To Show Rapid,Durable Changes
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Quite A Few (Clinical) Trials, No Tribulations -- Pipeline Progress Continues
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Hustle For The Muscle As EWTX''s Pipeline Efforts Advance
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
EDG-7500 Unveil Kicks Off The New Year In HCM Event
Provider: Wedbush Securities Inc.
Analyst: CHICO L